These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36724977)

  • 41. Comparative taste-masking evaluation of microencapsulated bitter drugs using Smartseal 30D and ReadyMix for paediatric dosage forms.
    Muoka LC; Ross SA; Mithu MSH; Nandi U; Douroumis D
    AAPS PharmSciTech; 2021 Apr; 22(4):141. PubMed ID: 33884533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HZT-501 (DUEXIS(®); ibuprofen 800 mg/famotidine 26.6 mg) gastrointestinal protection in the treatment of the signs and symptoms of rheumatoid arthritis and osteoarthritis.
    Schiff M; Peura D
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):25-35. PubMed ID: 22149579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
    Cipriano M; Björklund E; Wilson AA; Congiu C; Onnis V; Fowler CJ
    Eur J Pharmacol; 2013 Nov; 720(1-3):383-90. PubMed ID: 24120370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Derivative emission spectrofluorimetry: Application to the analysis of newly approved FDA combination of ibuprofen and famotidine in tablets.
    Ragab MA; El-Kimary EI
    Luminescence; 2015 Sep; 30(6):760-7. PubMed ID: 25421838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nasal NSAIDs for Alzheimer's Disease.
    Lehrer S
    Am J Alzheimers Dis Other Demen; 2014 Aug; 29(5):401-3. PubMed ID: 24413537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of bitterness of antihistaminic drugs by complexation with β-cyclodextrins.
    Ono N; Miyamoto Y; Ishiguro T; Motoyama K; Hirayama F; Iohara D; Seo H; Tsuruta S; Arima H; Uekama K
    J Pharm Sci; 2011 May; 100(5):1935-43. PubMed ID: 21374625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A novel class of anti-inflammatory and analgesic drugs--NO-donating NSAIDs].
    Zhang YH; Ji H; Peng SX
    Yao Xue Xue Bao; 2007 Apr; 42(4):352-7. PubMed ID: 17633199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bitterness evaluation of medicines for pediatric use by a taste sensor.
    Ishizaka T; Miyanaga Y; Mukai J; Asaka K; Nakai Y; Tsuji E; Uchida T
    Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):943-8. PubMed ID: 15304986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A fixed-dose combination ibuprofen and famotidine (Duexis).
    Med Lett Drugs Ther; 2011 Oct; 53(1376):85-6. PubMed ID: 22033211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ion-exchange complex of famotidine: sustained release and taste masking approach of stable liquid dosage form.
    Aman RM; Meshali MM; Abdelghani GM
    Drug Discov Ther; 2014 Dec; 8(6):268-75. PubMed ID: 25639307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Editorial: single-tablet ibuprofen/double-dose famotidine for reduction of gastric and duodenal ulcers (REDUCE Trials): what can be reduced?
    Chan FK
    Am J Gastroenterol; 2012 Mar; 107(3):387-8. PubMed ID: 22388022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Longer analgesic effect with naproxen sodium than ibuprofen in post-surgical dental pain: a randomized, double-blind, placebo-controlled, single-dose trial.
    Cooper SA; Desjardins P; Brain P; Paredes-Diaz A; Troullos E; Centofanti R; An B
    Curr Med Res Opin; 2019 Dec; 35(12):2149-2158. PubMed ID: 31402718
    [No Abstract]   [Full Text] [Related]  

  • 53. Bitter taste masking of enzyme-treated soy protein in water and bread.
    Bertelsen AS; Laursen A; Knudsen TA; Møller S; Kidmose U
    J Sci Food Agric; 2018 Aug; 98(10):3860-3869. PubMed ID: 29363768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of bitterness suppression of macrolide dry syrups by jellies.
    Tsuji E; Uchida T; Fukui A; Fujii R; Sunada H
    Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):310-4. PubMed ID: 16508183
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition by non-steroidal anti-inflammatory drugs of compound action potentials in frog sciatic nerve fibers.
    Suzuki R; Fujita T; Mizuta K; Kumamoto E
    Biomed Pharmacother; 2018 Jul; 103():326-335. PubMed ID: 29665554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Taste-masking effect of physical and organoleptic methods on peppermint-scented orally disintegrating tablet of famotidine based on suspension spray-coating method.
    Sugiura T; Uchida S; Namiki N
    Chem Pharm Bull (Tokyo); 2012; 60(3):315-9. PubMed ID: 22382410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Novel Method to Mask the Bitter Taste of Berberine Hydrochloride: Powder Surface Modification.
    Jiang H; Zhang D; He J; Han X; Lin J; Lan Y; Xiong X; Yu L; Yang M; Han L
    Pharmacogn Mag; 2018; 14(54):253-260. PubMed ID: 29720841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.
    Ziesenitz VC; Welzel T; van Dyk M; Saur P; Gorenflo M; van den Anker JN
    Paediatr Drugs; 2022 Nov; 24(6):603-655. PubMed ID: 36053397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of non-steroidal anti-inflammatory drugs on antiplatelet effect of aspirin.
    Yokoyama H; Ito N; Soeda S; Ozaki M; Suzuki Y; Watanabe M; Kashiwakura E; Kawada T; Ikeda N; Tokuoka K; Kitagawa Y; Yamada Y
    J Clin Pharm Ther; 2013 Feb; 38(1):12-5. PubMed ID: 22882748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent Advances in Bitterness-Sensing Systems.
    Li Y; Langley N; Zhang J
    Biosensors (Basel); 2023 Mar; 13(4):. PubMed ID: 37185489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.